Psychocutaneous diseases refer to skin conditions that have a psychological component. These conditions can range from mild to severe and may be caused by a variety of factors, such as stress, anxiety, and depression. The psychological component of these diseases can contribute to the onset, exacerbation, or persistence of skin symptoms, such as itching, rash, and pain.

In dermatology, there are various agents used for the treatment of psychocutaneous diseases. These agents may act through different mechanisms, such as modulating neurotransmitter levels in the brain.

The management of psychocutaneous diseases involves a multidisciplinary approach, with the involvement of dermatologists, psychiatrists, and other mental health professionals. Treatment may include both pharmacological and non-pharmacological interventions.

In this learning module, you will find a comprehensive review of the different pharmacological agents used for the treatment of psychocutaneous diseases, their mechanisms of action, indications, contraindications, adverse effects, and drug interactions.

To test your knowledge, we invite you to complete the associated quiz.

Select how you would like to proceed below:

1. Bolognia J, Schaffer JV, Cerroni L. Dermatology. 4th edition ed: Philadelphia, Pa.: Elsevier; 2018 9th November 2017. 2880 p.
2. Wolverton SE, Wu JJ. Comprehensive dermatologic drug therapy. 4th edition ed: Philadelphia, PA: Elsevier; 2021 19th March 2020. 1024 p.